SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-109669
Filing Date
2021-04-08
Accepted
2021-04-08 09:06:29
Documents
4
Period of Report
2021-04-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d89876d8k.htm 8-K 23825
2 EX-1.1 d89876dex11.htm EX-1.1 190427
3 EX-5.1 d89876dex51.htm EX-5.1 8613
4 GRAPHIC g89876dsp43.jpg GRAPHIC 3290
  Complete submission text file 0001193125-21-109669.txt   228946
Mailing Address 40 GUEST STREET SUITE 4410 BOSTON MA 02135
Business Address 40 GUEST STREET SUITE 4410 BOSTON MA 02135 617-409-5300
YUMANITY THERAPEUTICS, INC. (Filer) CIK: 0001445283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37695 | Film No.: 21813899
SIC: 2834 Pharmaceutical Preparations